Basic Information
FUCIDIN H CREAM
CREAM
Regulatory Information
SIN10834P
March 24, 1999
Prescription Only
Therapeutic
TOPICAL
August 10, 2023
June 4, 2025
XD07CA01
Company Information
Active Ingredients
Strength: 20 mg/g
Strength: 10 mg/g
Detailed Information
Contraindications
**Contraindications** Hypersensitivity to fusidic acid/sodium fusidate, hydrocortisone acetate or to any of the excipients listed above (see Composition – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). Due to the content of corticosteroid, Fucidin® H is contraindicated in the following conditions: Primary skin infections caused by fungi, virus or bacteria, either untreated or uncontrolled by appropriate treatment (see Special warnings and precautions for use – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). Skin manifestations in relation to tuberculosis, either untreated or uncontrolled by appropriate therapy. Perioral dermatitis and rosacea.
Indication Information
**Indications** Fucidin® H Cream is indicated for the treatment of dermatitis, including atopic dermatitis and contact dermatitis, where an infection with bacteria sensitive to fusidic acid is suspected or confirmed. Because of its hydrocortisone content, Fucidin® H Cream is particularly appropriate in cases where a milder corticosteroid is indicated, including milder inflammatory dermatoses – on the face and on children’s skin. Fucidin® H Cream is cosmetically acceptable for use on the face and hands and convenient for use in the armpits.